Quick Comparison
| Citicoline (CDP-Choline) | Ginkgo Biloba | |
|---|---|---|
| Half-Life | 56-71 hours (sustained release characteristics) | 3-10 hours (varies by constituent) |
| Typical Dosage | Standard: 250-500 mg daily. Clinical studies use 500-2000 mg daily. Take in the morning — mildly stimulating. Cognizin is the most studied form. Can be split into 2 doses. Often combined with racetams to provide the choline needed for enhanced acetylcholine turnover. | Standard: 120-240 mg daily of standardized extract (24% flavone glycosides, 6% terpene lactones). EGb 761 is the most studied form. Often taken in 2-3 divided doses. |
| Administration | Oral (capsules, powder). Cognizin branded form is most studied. Take in the morning. | Oral (capsules, tablets, liquid extract). Standardized extract recommended over raw leaves. |
| Research Papers | 10 papers | 9 papers |
| Categories |
Mechanism of Action
Citicoline (CDP-Choline)
Citicoline (CDP-choline) is hydrolyzed in the gut by alkaline phosphatase to choline and cytidine-5'-monophosphate, which are absorbed separately and reassembled in the brain via the Kennedy pathway. Choline feeds two critical pathways: (1) Acetylcholine synthesis via choline acetyltransferase (ChAT) — the primary memory and learning neurotransmitter acting at muscarinic and nicotinic receptors. (2) Phosphatidylcholine synthesis via CTP:phosphocholine cytidylyltransferase — the structural component of neuronal membranes and synaptic vesicles. Cytidine is dephosphorylated to uridine, converted to UTP, and supports RNA synthesis and CDP-choline formation for synapse formation. Citicoline also activates SIRT1 (possibly via NAD+ modulation) and increases brain norepinephrine and dopamine (mechanism unclear — may enhance synthesis or release). It is the only choline source providing both cholinergic and membrane-building support in one molecule.
Ginkgo Biloba
Ginkgo biloba extract (EGb 761) contains flavonoids (quercetin, kaempferol, isorhamnetin) and terpenoids (ginkgolides A, B, C, J and bilobalide). The flavonoids are potent antioxidants that scavenge superoxide, hydroxyl radicals, and peroxynitrite, and protect neurons from oxidative damage; they may also chelate iron. The terpenoids (ginkgolides and bilobalide) improve blood flow by antagonizing platelet-activating factor (PAF) at the PAF receptor, which reduces platelet aggregation, blood viscosity, and improves microcirculation in the brain. Bilobalide protects mitochondria and reduces apoptosis. Ginkgo modulates nitric oxide (NO) availability via endothelial nitric oxide synthase (eNOS) for vasodilation. It inhibits monoamine oxidase A and B (MAO-A, MAO-B), mildly elevating dopamine and serotonin. It may enhance cholinergic transmission and reduce amyloid aggregation.
Risks & Safety
Citicoline (CDP-Choline)
Common
Headache (especially with racetams — indicates too much cholinergic stimulation), nausea, diarrhea.
Serious
None documented at standard doses.
Rare
Insomnia, blurred vision.
Ginkgo Biloba
Common
Headache, dizziness, gastrointestinal discomfort, allergic skin reactions.
Serious
Increased bleeding risk — do not combine with blood thinners (warfarin, aspirin) or take before surgery.
Rare
Seizures (particularly with raw seeds, not standardized extract), severe allergic reactions.
Full Profiles
Citicoline (CDP-Choline) →
A naturally occurring intermediate in the synthesis of phosphatidylcholine, the primary phospholipid in neuronal cell membranes. Citicoline provides both choline (for acetylcholine and phospholipid synthesis) and cytidine (converted to uridine, supporting RNA and synapse formation). It is prescribed in Europe and Japan for stroke recovery and cognitive decline. Cognizin is the most studied branded form.
Ginkgo Biloba →
One of the oldest living tree species on Earth, used in traditional Chinese medicine for millennia. Ginkgo extract (EGb 761) is one of the most prescribed herbal medicines in Europe for cognitive decline and cerebrovascular insufficiency. It improves cerebral blood flow, has antioxidant properties, and modulates neurotransmitter systems. Most effective in older adults with declining cognitive function.